← Back to Clinical Trials
Recruiting NCT06298136

NCT06298136 The Effects of an Online Mindfulness-based Intervention for Children with Attention-Deficit/Hyperactivity Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06298136
Status Recruiting
Phase
Sponsor The Hong Kong Polytechnic University
Condition ADHD
Study Type INTERVENTIONAL
Enrollment 208 participants
Start Date 2024-02-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
mindfulness-based interventionchild behavior management

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 208 participants in total. It began in 2024-02-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will investigate the effects of an online mindfulness-based intervention with a randomized controlled trial.

Eligibility Criteria

Inclusion Criteria: * parents of children diagnosed with ADHD by a psychiatrist and psychologist according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Ed (DSM-5) * parents of children with ADHD aged 6 to 12. * Parents who have served as the primary caregivers of their children in the last year and children with ADHD who speak and understand Cantonese Chinese. * Children either not taking any medication or maintaining a stable dosage of the same ADHD medication for at least 3 months prior to study enrollment and having no plans to change medication and dosage during the study period. Exclusion Criteria: * parents diagnosed with developmental disabilities, psychosis, or cognitive impairment, who may thus have difficulty comprehending the content of the project. * Children with another developmental disability such as autistic spectrum disorder or intellectual disability. * Parents who completed an eight-week MBI or equivalent program.

Contact & Investigator

Central Contact

Herman Hay Ming Lo, PhD

✉ herman.lo@polyu.edu.hk

📞 +85296279830

Principal Investigator

Herman Hay Ming Lo, PhD

PRINCIPAL INVESTIGATOR

The Hong Kong Polytechnic University

Frequently Asked Questions

Who can join the NCT06298136 clinical trial?

This trial is open to participants of all sexes, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06298136 currently recruiting?

Yes, NCT06298136 is actively recruiting participants. Contact the research team at herman.lo@polyu.edu.hk for enrollment information.

Where is the NCT06298136 trial being conducted?

This trial is being conducted at Hong Kong, Hong Kong.

Who is sponsoring the NCT06298136 clinical trial?

NCT06298136 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Herman Hay Ming Lo, PhD at The Hong Kong Polytechnic University. The trial plans to enroll 208 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology